PROCEPT BioRobotics Corporation (PRCT) Misses Q4 EPS by 10c

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) reported Q4 EPS of ($0.54), $0.10 worse than the analyst estimate of ($0.44). Revenue for the quarter came in at $43.6 million versus the consensus estimate of $41.49 million.

For earnings history and earnings-related data on PROCEPT BioRobotics Corporation (PRCT) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• StoneX Reiterates Hold Rating on Old Dominion Freight Line (ODFL) on QTD Operating Metrics
• Attention Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Hub Group, Inc. (NASDAQ: HUBG); Hyliion Holdings Corp. (NYSE: HYLN); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Off